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Abstract 
 
Artificial pancreas is simulated to handle Type I diabetic patients under intensive care by automatically controlling 
the insulin infusion rate. A Backstepping technique is used to apply the effect of PID controller to blood glucose level 
since there is no direct relation between insulin infusion (the manipulated variable) and glucose level in Bergman’s 
system model subjected to an oral glucose tolerance test by applying a meal translated into a disturbance. Backstepping 
technique is usually recommended to stabilize and control the states of Bergman's class of nonlinear systems. The 
results showed a very satisfactory behavior of glucose deviation to a sudden rise represented by the meal that increase 
the blood glucose 
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1. Introduction 
 
With more than 246 million affected people 
worldwide, diabetes mellitus is one of the most 
widespread diseases and causes 3.8 million deaths 
per year, similar to HIV/AIDS [1]. Any patient 
that suffers from diabetes that does properly 
receives the insulin cure can lead to complications 
such as nerve damage, brain damage, amputation 
and eventually death. Diabetes related 
complications are a worldwide epidemic with 
high medical, economic and social costs [2]. The 
normal blood glucose concentration level in the 
human body varies in a narrow range (70 - 110 
mg/dL). If for some reason the human body is 
unable to control the normal glucose-insulin 
interaction (e.g. the glucose concentration level is 
constantly out of the above mentioned range), 
diabetes is diagnosed. As a result four types of 
diabetes are known: Type I (also known as 
insulin-dependent diabetes mellitus), Type II (or 
insulin-  independent diabetes mellitus), 
gestational diabetes and other special types, like 
genetic deflections [3]. 
Type I diabetes mellitus is characterized by 
theinability of the beta cells of the pancreas islets 
to produceinsulin, which is essential for the 
uptake of glucose in themuscles and storage in the 
liver [1].As known, insulin dosing is divided into 
two divisions: basal and bolus insulin. The basal 
insulin is required for fasting conditions; while 
bolus insulin is calculated to correct for meals or 
hyperglycemia condition. Both dosages should be 
adjusted over time. The development of external 
insulin infusion pumps as well as the introduction 
of rapid-acting insulin analogues has made 
automated intensive insulin therapy feasible [4]. 
Automatic controllers are needed to adjust the 
insulin therapy according to the measurements of 
glucose concentrations as illustrated in figure (1). 
Automatic control of insulin infusion rate 
especially for type I diabetes proved its ability to 
give satisfactory results.  Different types of 
automatic controllers are used in the literature. A. 
Makroglou  et al[5]  introduced an overview of 
some of the mathematical models appearing in the 
literature for use in the glucose-insulin regulatory 
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survey on available software. While L. Kovács et 
al [6] presented a practical method for designing 
arobust controller to regulate glucose-insulin 
system for Type 1 diabetic patients under 
intensive care. Also L. Kovács et al [7] 
investigated the possibility of using a reduced 
order estimator for the three-state minimal 
Bergman model.  F. H. El-Khatib et al [8] used an 
automated adaptive glucose-control system to 
regulate blood glucose, and showedthe 
plausibility and practicality of closed-loop blood-
glucose control using subcutaneous insulin and 
glucagon infusion in Type I diabetes. G. Marchetti 
et al [9] proposed a new glucose control strategy 
based on a novel combination of insulin boluses 
for meals and an improved PID control algorithm. 
H. Kirchsteiger et al [1] showed that it is possible 
to improve the common treatment of Type I 
diabetic patients by optimization of the time and 
quantity of single subcutaneous insulin injections. 
Y. Wang et al [4] proposed an algorithm can take 
advantage of frequent glucose measurement to 
design the basal and bolus insulin simultaneously. 
Two modern robust control methods are applied 
by L. Kovács et al [10]   the minimal model of 
Bergman: the disturbance rejection LQ control or 
minimax control and the robust H∞ control.  
In this work back stepping based PID 
controller analyzed and simulated the three states 
Bergman model which is the widely used 
mathematical model due to its simplicity. 
 
 
Fig.1. Feedback Control for Blood Glucose. 
 
2.     Bergman's system model 
 
Several different models of diabetic 
systemsexist,  for example the very detailed 21th-
order metabolic model of Sorensen. However, to 
have a system that on one hand, can be readily 
handled from the point of view of control design, 
but on the other hand represents the biological 
process properly, the Bergman’s three-state 
minimal patient model is considered.[6,7,10] 
 
                           …(1) 
 
Where  G(t) is the plasma glucose 
concentration above the basal level GB (mg/dL), 
X(t) (1/min)is remote compartment insulin 
utilization,  Y(t)  is the plasma insulin 
concentration above a basal value  YB (mU/dL). 
The control variable is theexogenous insulin 
infusion rate,  i(t) (mU/min), whereas the 
exogenous glucose infusion rate  h(t) (mg/dL 
min)represents the disturbance.VL(dL) 
representsthe insulin distribution volume and p1, 
p2, p3, p4 represent the model parameters. As 
numerical values the authors worked with the 
numerical values determined by: p1 = 0.028, p2 = 
0.025, p3 = 0.00013, p4 = 5/54, GB = 110, YB = 
1.5, VL = 120[6].In order to linearize the system, 
its steadystate values are needed: G0 = X0 = Y0 = 
0, h0 = 0, and for i0= p4Y BV L= 16.667,The system 
proved to be stable, controllable and observable 
[10]. 
 
 
3. Backstepping Based PID Controller 
 
A Backstepping technique is proposed to 
backbone the design of the PID controller. 
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1990 by Petar V. Kokotovic and others, for 
designing stabilizing controls for a special class of 
nonlinear dynamical. These systems are built from 
subsystems that radiate out from an irreducible 
subsystem that can be stabilized using some other 
method. Because of this recursive structure, the 
designer can start the design process at the 
known-stable system and "back out" new 
controllers that progressively stabilize each outer 
subsystem. The process terminates when the final 
external control is reached. Hence, this process is 
known as backstepping[11]. 
To apply the Backstepping approach, each of 
the three equations in (1) is considered separately. 
Now starting from the first equation: the state is 
regarded as the plasma glucose deviation   
(mg/dL), the virtual input is the remote 
compartment insulin utilization   (1/min) and 
the disturbance is the exogenous glucose infusion 
rate   (mg/dL min). A P controller is designed 
with   as a virtual input.  
The second equation considered which has the 
remote compartment insulin utilization   as a 
state variable and the plasma insulin deviation 
as the virtual input is considered. The virtual 
input for the second system will be designed to 
regulate the error   between the remote 
compartment insulin utilization , the state, 
and its value as a virtual input   (desired value) 
in the first equation. Again a P controller for the 
second virtual input  is designed. 
Finally, the actual controller  will be used 
as a PID controller to regulate the difference 
between the plasma insulin deviation  and its 
value as a virtual controller  as shown in Figure 
(2).  In addition, consider the following: 
All the parameters in equation (1) are 
uncertain but bounded; the disturbance is 
unknown but a bounded quantity, namely 
                                                    …(2) 
and also, 
                        …(3) 
The two virtual controllers and the actual 
controller are bounded: 
   
              ...(4) 
 
 
 
Fig.2.Back Stepping Based PID Approach Used 
with Bergman's Model. 
 
 
4. Simulation Results 
 
Bergman's model comes with an artificial 
pancreas with two inputs: the ingested glucose in 
plasma after a meal reflected by the disturbance 
function h(t) and insulin from an external 
injection i(t) that plays the controllers role.  
The disturbance function employed here is 
smooth, continuously differentiable, has zero 
initial conditions, easily implemented and 
physiologically accurate function [2]: 
                               …(5) 
Where hmis the peak value, a, b, c are constants 
which determine the exact shape. 
Figure (3) shows the normal behavior of 
Bergman's model when exposed to the 
disturbance which is the oral glucose tolerance 
test OGTT. There is a monotonic rise in the basal 
blood sugar by 32 mg/dL until the normal insulin 
initially existed treats this rise and guide it again 
to its basal level within . Figure (4) 
illustrates the disturbance of oral food ingestion 
model. 
The Backstepping approach determines how to 
stabilize the  subsystem using  , and then 
proceeds with determining how to derive the real 
control action on i to make the next state   drive 
 to the control required to stabilize  . 
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Fig .3. Normal Plasma Glucose Deviation in 
Response to OGTT. 
 
 
 
 
Fig.4. Exogenous Glucose Infusion (OGTT). 
 
 
Hence there are three control actions to 
stabilize each state backward. Theactual input 
signal the insulin infusion rate is controlled by 
PID controller tuned to kP3 =0.0627, ki =0.0010, 
kd=  0.8240 to stabilize the plasma insulin 
deviation y(t),  at this step a P controller is 
designed with   to stabilize remote 
compartment insulin utilization  , which 
finally derives the glucose deviation   to the 
originusing unity proportional controller 
( ) when the system issubjected to the 
meal disturbance illustrated previously; the 
glucose deviation response of figure (5) is 
obtained and the basal glucose level is illustrated 
in figure (6). Figure (7) illustrates the insulin 
infusion rate while the other systems states are in 
figures (8, 9). 
 
 
 
Fig.5. Controlled Plasma Glucose Deviation Using 
Backstepping Based PID Controller Exposed to 
OGTT. 
 
 
 
Figure (6): basal glucose level controlled by 
Backstepping PID. 
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Fig.7. Backstepping PID Controlled Insulin 
Infusion Rate. 
 
 
 
Fig.8. plasma Insulin Utilization Controlled By 
Backstepping PID. 
 
 
The Backstepping PID perfectly enhanced the 
glucose transient response to have a maximum 
peak of 0.8 mg/dL which is less than 1% of basal 
level GB=110, also it guided the blood glucose 
through controlling the insulin infusion rate to the 
basal level very fast in    
Backstepping technique was very useful to gain 
this excellent behavior with the three control and 
stabilizing steps.  
 
 
 
Fig.9. Plasma Insulin Deviation Controlled by 
Backstepping PID . 
 
 
These results are compared to those obtained 
by L. Kovács et al [10] who used modified 
Minimax, LQ and  controllers to regulate insulin 
infusion rate as illustrated in table (1). 
 
Table (1) 
Controller  Settlin
g time 
(min.) 
Glucose 
Peak 
(mg/dL) 
Insulin 
infusion 
highest level 
(mU/min.) 
Minimax  252  11.7  18.3 
LQ  374  24.6  17.5 
 
456.25  16.5  33.25 
Backstepping 
PID 
570  0.8  19 
 
 
5. Conclusions 
 
Glucose deviation of Bergman's model for 
artificial pancreas is regulated by designing 
Backstepping PID controller that directs the 
insulin infusions rate which stabilize the other two 
states backward until the glucose deviation is 
driven to zero after it's excitation by a sudden 
meal disturbance function that represents the Taghreed M. Mohammad            Al-Khwarizmi Engineering Journal, Vol. 7, No. 4, PP 54 -60  (2011) 
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OGTT. Excellent behavior is obtained on both 
aspects moderate speed and minimum overshoot. 
The results are compared to these presented by L. 
Kovacs. The proposed controller proved a very 
efficient behavior by giving the lowest glucose 
deviation peak even less than 1% of the basal 
level in 213min. Backstepping technique is very 
much recommended to control such class of 
nonlinear systems and it is a good base to design 
any controller like PID that was fairly capable of 
handling the regulatory problem. 
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ﺔﺻﻼﺨﻟا   
  
ﻜﻨﺑ ﺬﯿﻔﻨﺗ ﻢﺗ  ﻰﻠﻋ ﮫﯿﻜﯿﺗﺎﻣﻮﺗوﻻا ةﺮﻄﯿﺴﻟا ﻖﯾﺮﻃ ﻦﻋ ﮫﺻﺎﺨﻟا ﺔﯾﺎﻋﺮﻟا ﺖﺤﺗ يﺮﻜﺴﻟا ضﺮﻣ ﻦﻣ لوﻻا عﻮﻨﻟا ﻰﺿﺮﻣ ﺔﺠﻟﺎﻌﻣ ﻢﺘﯿﻟ ﻲﻋﺎﻨﺻ سﺎﯾﺮ
ﻦﯿﻟﻮﺴﻧﻻا ﺦﺿ ﺔﺒﺴﻧ  . ﻲﺒﺳﺎﻨﺘﻟا ﺮﻄﯿﺴﻤﻟا ﺮﯿﺛﺄﺗ ﺔﻓﺎﺿﻻ ﺖﻣﺪﺨﺘﺳا ﻲﺘﻟا ﻲھ ﮫﯿﻌﺟاﺮﺘﻟا تاﻮﻄﺨﻟا ﺔﯿﻨﻘﺗ - ﻲﻠﻣﺎﻜﺘﻟا -  ﻲﻓزﻮﻛﻮﻠﺠﻟا ىﻮﺘﺴﻣ  ﻰﻠﻋ ﻲﻠﺿﺎﻔﺘﻟا
مﺪﻟا  , ﻨھ ﺲﯿﻟ ﮫﻧا ﺎﻤﺑ  ﻲﻓ مﺪﻟا ﻲﻓ زﻮﻛﻮﻠﺠﻟا ﺔﺒﺴﻧو ﻦﯿﻟﻮﺴﻧﻻا ﺦﺿ ﻮھو ﺮﯿﻐﺘﻤﻟا ﻞﻣﺎﻌﻤﻟا ﻦﯿﺑ  ةﺮﺷﺎﺒﻣ ﮫﻗﻼﻋ كﺎ جذﻮﻤﻧ   Bergman    ضﺮﻌﺗ يﺬﻟاو
ﻛ مﺎﻌﻃ ﺔﺒﺟو ﻖﯿﺒﻄﺘﺑ ﻲﮭﻔﺸﻟا ﺮﻜﺴﻟا ﻞﻤﺤﺗ رﺎﺒﺘﺧﻻ ﻲﺟرﺎﺧ باﺮﻄﺿﺎ  .  ةﺮﻄﯿﺴﻟا و راﺮﻘﺘﺳﻻا ﻖﯿﻘﺤﺘﻟ ﺎﮭﺑ ﻰﺻﻮﻣ ةدﺎﻋ ﻲھ ﮫﯿﻌﺟاﺮﺘﻟا تاﻮﻄﺨﻟا ﺔﯿﻨﻘﺗ
 ﻂﻤﻧ تﻻﺎﺣ ﻰﻠﻋ Bergman    ﻦﻣ ﺔﯿﻄﺧﻼﻟا ﺔﻤﻈﻧﻻا .  ﻲﺘﻟاو ﺔﺒﺟﻮﺑ ﻞﺜﻤﻣ ﺊﺟﺎﻔﻣ عﺎﻔﺗرﻻ زﻮﻛﻮﻠﺠﻟا ﺔﺑﺎﺠﺘﺳﻻ اﺪﺟ ﻊﻨﻘﻣ فﺮﺼﺗ ﺞﺋﺎﺘﻨﻟا ﺖﺤﺿوا ﺪﻗ
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